Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Black

Orthopaedic Surgery Florham Park, NJ Medical Doctor

NPI 1982863338 CMS profile 1188530

140 Park Ave, Florham Park, NJ 07932

Open in the dashboard

General payments

$453,231

312 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Black of Florham Park, NJ is reported in the CMS Open Payments database as having received $453,231 across 312 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $347,328 135
2024 General $35,716 66
2023 General $18,438 49
2022 General $19,830 14
2021 General $6,467 19
2020 General $19,929 16
2019 General $5,524 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Black
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Eric Black were reported at $347,328. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Eric Black Orthopaedic Surgery median Middle half National median
2019 $5,524 $644 $140–$2,844 $163
2020 $19,929 $312 $75–$1,860 $114
2021 $6,467 $520 $117–$2,495 $132
2022 $19,830 $598 $128–$2,731 $149
2023 $18,438 $461 $128–$2,264 $160
2024 $35,716 $497 $134–$2,475 $164
2025 $347,328 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $380,229 187 payments
  2. Stryker Corporation $45,271 68 payments
  3. Wright Medical Technology, Inc. $20,762 20 payments
  4. Smith+Nephew, Inc. $2,722 4 payments
  5. Arthrex, Inc. $2,548 7 payments
  6. SeaPearl Inc $1,238 12 payments
  7. DePuy Synthes Sales Inc. $146 2 payments
  8. Bioventus LLC $146 6 payments
  9. Ferring Pharmaceuticals Inc. $79 4 payments
  10. Encore Medical, LP $72 1 payment
  11. Other $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $379,808 51 payments
  2. Education $32,533 9 payments
  3. Travel and Lodging $25,505 94 payments
  4. Food and Beverage $9,292 155 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,094 3 payments
Products named General payments · program years 2019–2025
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $37,542 50 payments
  2. Tapestry $28,557 7 payments
  3. SIMPLICITI Upper Extremities $15,444 7 payments
  4. AEQUALIS PERFORM $9,856 4 payments
  5. Alliance $3,465 2 payments
  6. BLUEPRINT PSI SYSTEM $2,930 6 payments
  7. Regeneten $2,677 3 payments
  8. SIMPLICITI Trauma & Extremities $2,468 4 payments
  9. TORNIER PERFORM REVERSED AUGMENTED GLENOID $2,431 3 payments
  10. AEQUALIS $2,388 7 payments
  11. Other $11,566 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

158

Median for Orthopedic Surgery: 203

Drug cost

$352

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 89 $197
Meloxicam Generic 47 $115
Clindamycin Hcl Generic 22 $40

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$465,361

Of which drugs: $3,688

Medicare patients

865

Average age 74

Services billed

6,213

512 women, 353 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 34%
Osteoporosis 24%
Diabetes 23%
Depression 19%
Cancer 17%
Chronic kidney disease 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 302 3,004 $2,301

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

312 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record